Company: TYRA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0000950170-25-108899
Chunk: 0

Company: Tyra Biosciences, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 1
Chunk 0
---
Tyra Biosciences, Inc.Condensed Balance Sheets

(in thousands, except share and per share data)

     June 30,

     December 31,

     2025

     2024

     (unaudited)

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     98,490

     $
     91,966

     Marketable securities

     197,781

     249,475

     Prepaid expenses and other current assets

     5,884

     6,022

     Total current assets

     302,155

     347,463

     Restricted cash

     1,000

     1,000

     Property and equipment, net

     1,413

     1,651

     Right-of-use assets

     5,822

     6,068

     Other long-term assets

     11,109

     7,376

     Total assets
      
     $
     321,499

     $
     363,558

     Liabilities and Stockholders’ Equity

     Current liabilities:

     Accounts payable
      
     $
     2,245

     $
     590

     Lease liabilities, current

     441

     412

     Accrued expenses and other current liabilities

     11,084

     13,592

     Total current liabilities

     13,770

     14,594

     Lease liabilities, noncurrent

     5,582

     5,810

     Other long-term liabilities

     —

     3

     Total liabilities

     19,352

     20,407

     Commitments and contingencies (Note 9)

     Stockholders’ equity:

     Preferred stock, $0.0001 par value; 50,000,000 shares    authorized at June 30, 2025 and December 31, 2024;     no shares issued and outstanding at June 30, 2025 and    December 31, 2024.

     —

     —

     Common stock, $0.0001 par value; 500,000,000 shares authorized    at June 30, 2025 and December 31, 2024; 53,233,494 and    50,754,262 shares issued